| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/108705719600100307 High Throughput Screen for Inhibitors of Bacterial DNA Topoisomerase I Using the Scintillation Proximity AssayDepartment of Antibacterial Discovery, Abbott Laboratories, Pharmaceutical Products Research Division, 100 Abbott Park Rd., Abbott Park, Illinois 60064-3500
Department of Antibacterial Discovery, Abbott Laboratories, Pharmaceutical Products Research Division, 100 Abbott Park Rd., Abbott Park, Illinois 60064-3500
Department of Biomolecular Screening, Abbott Laboratories, Pharmaceutical Products Research Division, 100 Abbott Park Rd., Abbott Park, Illinois 60064-3500
Department of Biomolecular Screening, Abbott Laboratories, Pharmaceutical Products Research Division, 100 Abbott Park Rd., Abbott Park, Illinois 60064-3500 We report the development of a rapid method to detect binding of supercoiled DNA to Escherichia coli topoisomerase I using the scintillation proximity assay (SPA). Streptavidin-SPA beads were coated with biotinylated topoisomerase I produced in vivo as a chimeric fusion protein. The hybrid biotinyl-fusion protein was overproduced in E. coli and purified in a single step by monomeric avidin affinity chromatography. The assay signal originates from both covalent and noncovalent binding of [3H]DNA to the SPA bead-immobilized enzyme. About 20-30% of the total [3H]DNA bound to the bead-immobilized enzyme remains associated with the bead in the presence of 0.5% SDS. The residual signal arises from the trapping of covalent [3H]DNA-enzyme complexes. The assay was employed in a high throughput screen that identified two general classes of topoisomerase inhibitors: agents that (1) inhibit DNA binding or (2) stabilize a covalent enzyme-DNA intermediate.
|